Exploring the incidence and etiopathogenesis of pathological yawning as adverse side effect of psychotropic drugs.

Q3 Pharmacology, Toxicology and Pharmaceutics
Neuropsychopharmacologia Hungarica Pub Date : 2023-12-01
Anusa Arunachalam Mohandoss, Rooban Thavarajah
{"title":"Exploring the incidence and etiopathogenesis of pathological yawning as adverse side effect of psychotropic drugs.","authors":"Anusa Arunachalam Mohandoss, Rooban Thavarajah","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Yawning is a normal, stereotyped physiological event in humans and animal kingdom. When excessive (>3 per 15 minutes), it is termed as pathological yawning (PY). PY could be due to many causes but more commonly associated with side-effect of drugs, notably involving those used in psychopharmacology. Though there are isolated case reports and case-series, there are no large-scale reports of PY. This work attempted to address this lacuna.</p><p><strong>Material and methods: </strong>The current work attempted to identify characteristics of PY as collated from adverse drug effect databases of Australia (Database of Adverse Event Notifications), Canada (Canada Vigilance Adverse Reaction Online Database) and the United States of America (FDA Adverse Event Reporting System - FAERS). These databases collect and provide public access to reports of adverse events related to drugs and therapeutic goods. They act as a prime pharmacovigilance tool as well as a first-line resource for healthcare professionals, researchers, and the public to monitor the safety of these products and make informed decisions. In the first week of June 2023, open access, unrestricted adverse effect of drug databases were explored, using the word \"YAWNING\" as the only search term for the side effect of any drug without any restrictions. The collected details of PY cases with their gender, age, reason for drug use, other concomitant complaints as well as the nature of adverse event(s) and its treatment requirements were assessed. Descriptive statistics were used.</p><p><strong>Result: </strong>Of the 2655 instances in USA database, 398(15%) had more than 1 suspect drug and in total 578 medications involved. The most commonly involved drugs were apomorphine, sertraline, fluoxetine and paroxetine. In all 341(12.8%) cases reported of YAWN alone or with one another sleep disorder, the most common off ending drug were fluoxetine hydrochloride.</p><p><strong>Discussion and conclusion: </strong>The neural mechanism and physiology of yawning are explained. This study stresses that a health care professional, particularly mental health professionals and neurologists, should be aware of the importance of PY to deliver the best for the patients under their care. \n\n(Neuropsychopharmacol Hung 2023; 25(4): 194-205)</p>","PeriodicalId":39762,"journal":{"name":"Neuropsychopharmacologia Hungarica","volume":"25 4","pages":"194-205"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuropsychopharmacologia Hungarica","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Yawning is a normal, stereotyped physiological event in humans and animal kingdom. When excessive (>3 per 15 minutes), it is termed as pathological yawning (PY). PY could be due to many causes but more commonly associated with side-effect of drugs, notably involving those used in psychopharmacology. Though there are isolated case reports and case-series, there are no large-scale reports of PY. This work attempted to address this lacuna.

Material and methods: The current work attempted to identify characteristics of PY as collated from adverse drug effect databases of Australia (Database of Adverse Event Notifications), Canada (Canada Vigilance Adverse Reaction Online Database) and the United States of America (FDA Adverse Event Reporting System - FAERS). These databases collect and provide public access to reports of adverse events related to drugs and therapeutic goods. They act as a prime pharmacovigilance tool as well as a first-line resource for healthcare professionals, researchers, and the public to monitor the safety of these products and make informed decisions. In the first week of June 2023, open access, unrestricted adverse effect of drug databases were explored, using the word "YAWNING" as the only search term for the side effect of any drug without any restrictions. The collected details of PY cases with their gender, age, reason for drug use, other concomitant complaints as well as the nature of adverse event(s) and its treatment requirements were assessed. Descriptive statistics were used.

Result: Of the 2655 instances in USA database, 398(15%) had more than 1 suspect drug and in total 578 medications involved. The most commonly involved drugs were apomorphine, sertraline, fluoxetine and paroxetine. In all 341(12.8%) cases reported of YAWN alone or with one another sleep disorder, the most common off ending drug were fluoxetine hydrochloride.

Discussion and conclusion: The neural mechanism and physiology of yawning are explained. This study stresses that a health care professional, particularly mental health professionals and neurologists, should be aware of the importance of PY to deliver the best for the patients under their care. (Neuropsychopharmacol Hung 2023; 25(4): 194-205)

探讨作为精神药物不良副作用的病理性打哈欠的发生率和病因。
简介打哈欠是人类和动物界的一种正常、刻板的生理现象。如果打哈欠次数过多(每 15 分钟超过 3 次),则被称为病理性打哈欠(PY)。打哈欠的原因有很多,但更常见的是与药物的副作用有关,尤其是精神药理学中使用的药物。虽然有个别病例报告和病例系列,但没有关于PY的大规模报告。本研究试图填补这一空白:本研究试图从澳大利亚(不良事件通知数据库)、加拿大(加拿大警戒不良反应在线数据库)和美国(FDA 不良事件报告系统 - FAERS)的药物不良反应数据库中找出PY的特征。这些数据库收集并向公众提供与药物和治疗用品有关的不良事件报告。它们是主要的药物警戒工具,也是医疗保健专业人员、研究人员和公众监测这些产品的安全性并做出明智决策的一线资源。2023 年 6 月的第一周,我们对开放存取、无限制的药物不良反应数据库进行了探索,以 "YAWNING "一词作为唯一的搜索关键词,对任何药物的副作用进行了无限制的搜索。对收集到的PY病例的性别、年龄、用药原因、其他并发症以及不良反应的性质和治疗要求进行了评估。结果:结果:在美国数据库中的 2655 个案例中,398 个(15%)有一种以上的可疑药物,共涉及 578 种药物。最常涉及的药物是阿朴吗啡、舍曲林、氟西汀和帕罗西汀。在所有 341 例(12.8%)单独或同时患有睡眠障碍的病例中,最常见的停药药物是盐酸氟西汀:本研究解释了打哈欠的神经机制和生理学。本研究强调,医护人员,尤其是精神卫生专业人员和神经科医生,应认识到打哈欠的重要性,以便为其护理的患者提供最佳治疗。(Neuropsychopharmacol Hung 2023; 25(4):194-205)
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neuropsychopharmacologia Hungarica
Neuropsychopharmacologia Hungarica Medicine-Medicine (all)
CiteScore
1.60
自引率
0.00%
发文量
8
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信